Literature DB >> 17657723

Ubiquitination, phosphorylation, and acetylation--triple threat in muscle wasting.

Per-Olof Hasselgren1.   

Abstract

Loss of muscle mass is commonly seen in patients with critical illness and is associated with increased expression of multiple genes controlling protein breakdown. Transcription factors that are activated during muscle wasting include NF-kB and members of the FOXO and C/EBP transcription factor families. The activity of these transcription factors is regulated by multiple posttranslational modifications, including ubiquitination, phosphorylation, and acetylation, providing for a complex and integrated network of regulatory mechanisms in muscle wasting. Targeting posttranslational modifications of transcription factors may prove important in the prevention and treatment of the debilitating consequences of muscle wasting. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657723     DOI: 10.1002/jcp.21190

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

Review 1.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 2.  Acetylation and deacetylation--novel factors in muscle wasting.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Per-Olof Hasselgren
Journal:  Metabolism       Date:  2012-05-22       Impact factor: 8.694

Review 3.  Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.

Authors:  Craig A Goodman; David L Mayhew; Troy A Hornberger
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

Review 4.  Current understanding of sarcopenia: possible candidates modulating muscle mass.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2014-05-07       Impact factor: 3.657

5.  Burn injury-induced IRS-1 degradation in mouse skeletal muscle.

Authors:  X-M Lu; Rg Tompkins; Aj Fischman
Journal:  Int J Burns Trauma       Date:  2013-01-24

6.  The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.

Authors:  Jacob J Elmer; Matthew D Christensen; Sutapa Barua; Jennifer Lehrman; Karmella A Haynes; Kaushal Rege
Journal:  Biotechnol Bioeng       Date:  2015-12-30       Impact factor: 4.530

Review 7.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

8.  Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-κB in muscle of mdx mice.

Authors:  Rakshita A Charan; Gabriela Niizawa; Hiroyuki Nakai; Paula R Clemens
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

9.  Acetylation of myocardin is required for the activation of cardiac and smooth muscle genes.

Authors:  Dongsun Cao; Chunbo Wang; Ruhang Tang; Huaqun Chen; Zheng Zhang; Mariko Tatsuguchi; Da-Zhi Wang
Journal:  J Biol Chem       Date:  2012-09-23       Impact factor: 5.157

Review 10.  Epigenetic drugs in the treatment of skeletal muscle atrophy.

Authors:  Valentina Guasconi; Pier Lorenzo Puri
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.